XVIVO receives Horizon 2020 funding
The European Commission has selected XVIVO Perfusion’s project “Biomarkers for clinical assessment of lungs intended for transplantation” for funding through the Research and Innovation Framework Program Horizon 2020.A total of 2,666 proposals were submitted to the first SME (Small Medium Enterprises) Instrument Calls within the European Commission´s newly established Research and Innovation Framework Program Horizon 2020. 155 projects from 21 countries were selected for funding of a phase I feasibility study. Each project receives €50,000 to perform a feasibility study and to prepare a